Positive autoregulation and repression of transactivation are key regulatory features of the Candida glabrata Pdr1 transcription factor
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Summary: Resistance to azole drugs, the major clinical antifungal compounds, is most commonly due to gain‐of‐function (GOF) substitution mutations in a gene called PDR1 in the fungal pathogen Candida glabrata. PDR1 encodes a zinc cluster‐containing transcription factor. GOF forms of Pdr1 drive high level expression of downstream target gene expression with accompanying azole resistance. PDR1 has two homologous genes in Saccharomyces cerevisiae, called Sc PDR1 and Sc PDR3. This study provides evidence that the PDR1 gene in C. glabrata represents a blend of the properties found in the two S. cerevisiae genes. We demonstrated that GOF Pdr1 derivatives are overproduced at the protein level and less stable than the wild‐type protein. Overproduction of wild‐type Pdr1 increased target gene expression but to a lesser extent than GOF derivatives. Site‐directed mutagenesis of Pdr1 binding sites in the PDR1 promoter provided clear demonstration that autoregulation of PDR1 is required for its normal function. An internal deletion mutant of Pdr1 lacking its central regulatory domain behaved as a hyperactive transcription factor that was lethal unless conditionally expressed. A full understanding of the regulation of Pdr1 will provide a new avenue of interfering with azole resistance in C. glabrata.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
A nuclear receptor-like pathway regulating multidrug resistance in fungi
Thakur, J. K., Arthanari, H., Yang, F., Pan, S.-J., Fan, X., Breger, J., Frueh, D. P., Gulshan, K., Li, D. K., Mylonakis, E., et al. (2008) · Nature · doi:10.1038/nature06836 · Cited by 343
Sanglard, D., Ischer, F., Calabrese, D., Majcherczyk, P. A., & Bille, J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2753 · Cited by 337 · cited 1×
“Elevated expression of CDR1 is required for the observed drug resistance seen in gain- of-function PDR1 strains (Sanglard et al., 1999).”
BackgroundCleveland, A. A., Harrison, L. H., Farley, M. M., Hollick, R., Stein, B., Chiller, T. M., Lockhart, S. R., & Park, B. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0120452 · Cited by 304
Regulation of multidrug resistance in pathogenic fungi
Morschhäuser, J. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.08.002 · Cited by 300 · cited 1×
“These mutations are typically substitution mutants that produce a factor that exhibits high-level transcriptional activation of target genes (reviewed in [Morschhauser, 2010; Paul and Moye-Rowley, 2014]).”
BackgroundFerrari, S., Ischer, F., Calabrese, D., Posteraro, B., Sanguinetti, M., Fadda, G., Rohde, B., Bauser, C., Bader, O., & Sanglard, D. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000268 · Cited by 295 · cited 5×
“Substitution mutant derivatives of Pdr1 were identified in clinical isolates using congenic strains that varied in their level of fluconazole resistance (Ferrari et al., 2009).”
BackgroundResultInfluentialVermitsky, J.-P., & Edlind, T. D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3773-3781.2004 · Cited by 285 · cited 2×
“Work from several labs found that the most frequent cause of azole resistance are mutations in the gene encoding a zinc cluster-containing transcription factor called Pdr1 (Vermitsky and Edlind, 2004; Tsai et al., 2006; Vermitsky et al., 2006).”
BackgroundVermitsky, J., Earhart, K. D., Smith, W. L., Homayouni, R., Edlind, T. D., & Rogers, P. D. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05235.x · Cited by 233
Yeast ATP-Binding Cassette Transporters Conferring Multidrug Resistance
Prasad, R., & Goffeau, A. (2012) · Annual Review of Microbiology · doi:10.1146/annurev-micro-092611-150111 · Cited by 221
Hallstrom, T. C., & Moye-Rowley, W. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007338200 · Cited by 194 · cited 10×
“Previously, we have shown that ScPdr3 can activate its target gene suites via engagement with either Med15- or Med12dependent mechanisms (Shahi et al., 2010).”
BackgroundMethodMultidrug resistance in fungi: regulation of transporter-encoding gene expression
Paul, S., & Moye-Rowley, W. S. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00143 · Cited by 137
MacCallum, D. M., Coste, A., Ischer, F., Jacobsen, M. D., Odds, F. C., & Sanglard, D. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01645-09 · Cited by 98 · cited 2×
“Name Background Genotype Reference ATCC2001 Wild-type ATCC MRY821 ATCC2001 his3D::FRT leu2D::FRT trp1D::FRT (MacCallum et al., 2010) MRY822 ATCC2001 pdr1D::natMX his3D::FRT leu2D::FRT trp1D::FRT (Paul et al., 2014) SPG96 ATCC2001 his3D::FRT leu2D::FRT trp1D::FRT ura3D(-85 1932)::Tn903NeoR This…”
Farmakiotis, D., Kyvernitakis, A., Tarrand, J. J., & Kontoyiannis, D. P. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.07.006 · Cited by 86
Regulation of the CgPdr1 Transcription Factor from the Pathogen Candida glabrata
Paul, S., Schmidt, J. A., & Moye-Rowley, W. S. (2011) · Eukaryotic Cell · doi:10.1128/ec.00277-10 · Cited by 78 · cited 8×
“We previously expressed the amino-terminal 300 residues of Pdr1 that were sufficient to produce DNA-binding activity (Paul et al., 2011).”
BackgroundShahi, P., Gulshan, K., Näär, A. M., & Moye-Rowley, W. S. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-10-0899 · Cited by 49
Paul, S., Bair, T. B., & Moye-Rowley, W. S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03921-14 · Cited by 45 · cited 6×
“The proteins were transferred to a nitrocellulose membrane, blocked with 5% nonfat dry milk, and then probed with antiPdr1 antibody (Paul et al., 2014) diluted 1:2,000–6,000.”
Method
Cited by
Vu, B. G., Thomas, G. H., & Moye-Rowley, W. S. (2019) · mBio · doi:10.1128/mbio.00934-19 · Cited by 59
Self-citationVu, B. G., Stamnes, M. A., Li, Y., Rogers, P. D., & Moye-Rowley, W. S. (2021) · PLOS Genetics · doi:10.1371/journal.pgen.1009582 · Cited by 39
Gale, A. N., Pavesic, M. W., Nickels, T. J., Xu, Z., Cormack, B. P., & Cunningham, K. W. (2023) · mSphere · doi:10.1128/msphere.00254-23 · Cited by 27
Hybrid adaptation is hampered by Haldane’s sieve
Bautista, C., Gagnon-Arsenault, I., Utrobina, M., Fijarczyk, A., Bendixsen, D. P., Stelkens, R., & Landry, C. R. (2024) · Nature Communications · doi:10.1038/s41467-024-54105-4 · Cited by 7
Hybrid adaptation is hampered by Haldane’s sieve
Bautista, C., Gagnon-Arsenault, I., Utrobina, M., Fijarczyk, A., Bendixsen, D. P., Stelkens, R., & Landry, C. R. (2023) · doi:10.1101/2023.12.15.571924 · Cited by 2
Metadata
- Authors
- Khakhina, S., Simonicova, L., & Moye‐Rowley, W. S.
- Venue
- Molecular Microbiology
- Publisher
- Wiley
- Published
- 2018-02-12
- Volume
- 107
- Issue
- 6
- Pages
- 747-764
- ISSN
- 0950-382X (ISSN-L)
- 1365-2958
- OpenAlex
- W2789821028
- Cited by
- 32
- References
- 16
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.